CA2150125A1 - Clone d'adnc pour l'oxide nitrique synthase inductible humaine et procede de preparation - Google Patents
Clone d'adnc pour l'oxide nitrique synthase inductible humaine et procede de preparationInfo
- Publication number
- CA2150125A1 CA2150125A1 CA002150125A CA2150125A CA2150125A1 CA 2150125 A1 CA2150125 A1 CA 2150125A1 CA 002150125 A CA002150125 A CA 002150125A CA 2150125 A CA2150125 A CA 2150125A CA 2150125 A1 CA2150125 A1 CA 2150125A1
- Authority
- CA
- Canada
- Prior art keywords
- nitric oxide
- oxide synthase
- leu
- inducible nitric
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
- C12N9/0075—Nitric-oxide synthase (1.14.13.39)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
- C12Y114/13039—Nitric-oxide synthase (NADPH dependent) (1.14.13.39)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98134492A | 1992-11-25 | 1992-11-25 | |
US981,344 | 1992-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2150125A1 true CA2150125A1 (fr) | 1994-06-09 |
Family
ID=25528300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002150125A Abandoned CA2150125A1 (fr) | 1992-11-25 | 1993-11-23 | Clone d'adnc pour l'oxide nitrique synthase inductible humaine et procede de preparation |
Country Status (5)
Country | Link |
---|---|
US (2) | US5468630A (fr) |
EP (1) | EP0670902A1 (fr) |
JP (1) | JPH08503852A (fr) |
CA (1) | CA2150125A1 (fr) |
WO (1) | WO1994012645A2 (fr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08503852A (ja) * | 1992-11-25 | 1996-04-30 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブハイヤー エデュケーション | ヒト誘導性一酸化窒素シンターゼのcDNAクローンおよびその作製方法 |
US5658565A (en) * | 1994-06-24 | 1997-08-19 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Inducible nitric oxide synthase gene for treatment of disease |
US5830461A (en) * | 1992-11-25 | 1998-11-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods for promoting wound healing and treating transplant-associated vasculopathy |
DE4411402A1 (de) * | 1994-03-31 | 1995-10-05 | Juergen Schrader | DNA-Expressionsvektoren zur Verwendung in der gentherapeutischen Behandlung von Gefäßerkrankungen |
US5744340A (en) * | 1995-06-09 | 1998-04-28 | Schering Corporation | Expression of human inducible nitric oxide synthase |
US5908842A (en) * | 1995-12-08 | 1999-06-01 | Merck & Co., Inc. | Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase |
WO1997034014A1 (fr) * | 1996-03-15 | 1997-09-18 | Yale University | Procedes et moyen de detection d'une synthase d'oxyde nitrique |
GB9607440D0 (en) * | 1996-04-10 | 1996-06-12 | Medical Res Council | Analysis of DNA |
US7198904B1 (en) * | 1996-04-12 | 2007-04-03 | Robert Webber | Immunoassay method employing monoclonal antibody reactive to human iNOS |
WO1997042965A1 (fr) * | 1996-05-10 | 1997-11-20 | Gonzalez Cadavid Nestor F | Amelioration de la dyserection |
US5856158A (en) * | 1996-07-05 | 1999-01-05 | University Of Iowa Research Foundation | Purified nitric oxide synthase from rat brain |
US20020076782A1 (en) * | 1996-07-05 | 2002-06-20 | John P.N. Rosazza | Purified nitric oxide synthase |
US6150500A (en) | 1996-07-12 | 2000-11-21 | Salerno; John C. | Activators of endothelial nitric oxide synthase |
US5789395A (en) * | 1996-08-30 | 1998-08-04 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
WO1998012313A1 (fr) * | 1996-09-20 | 1998-03-26 | Suntory Limited | Procede de tri de composes regulateurs de l'expression de la synthase induisant chez l'homme la production d'acide nitrique |
US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
JP4117911B2 (ja) * | 1997-04-11 | 2008-07-16 | ロバート ウェバー | ヒトiNOSに反応するモノクロナール抗体を用いる免疫学的検定法 |
AU3775799A (en) | 1998-05-01 | 1999-11-23 | University Of Pittsburgh | Muscle-derived cell mediated gene delivery for treating muscle- and bone-relatedinjury or dysfunction |
US20040043068A1 (en) * | 1998-09-29 | 2004-03-04 | Eugene Tedeschi | Uses for medical devices having a lubricious, nitric oxide-releasing coating |
AUPQ577700A0 (en) * | 2000-02-22 | 2000-03-16 | K. King & Co Pty Limited | Method of treatment of anorectal disorders |
US6270779B1 (en) | 2000-05-10 | 2001-08-07 | United States Of America | Nitric oxide-releasing metallic medical devices |
US6620616B1 (en) | 2000-09-13 | 2003-09-16 | The Cleveland Clinic Foundation | Nucleic acids encoding nitric oxide synthase variants |
EP1436018A1 (fr) * | 2001-09-26 | 2004-07-14 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Dispositifs medicaux revetus a liberation d'oxyde nitrique et leur procede de preparation |
US6703046B2 (en) | 2001-10-04 | 2004-03-09 | Medtronic Ave Inc. | Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
CA2545584C (fr) | 2003-11-17 | 2012-10-23 | Biomarin Pharmaceutical Inc. | Methodes et compositions destinees au traitement de troubles metaboliques |
BRPI0517088A (pt) * | 2004-11-17 | 2008-09-30 | Biomarin Pharm Inc | formulação de comprimido estável |
US8021679B2 (en) | 2005-08-25 | 2011-09-20 | Medtronic Vascular, Inc | Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore |
US20070053952A1 (en) * | 2005-09-07 | 2007-03-08 | Medtronic Vascular, Inc. | Nitric oxide-releasing polymers derived from modified polymers |
WO2007053292A2 (fr) * | 2005-10-31 | 2007-05-10 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Diazeniumdiolates lies par un carbone, liberant de l'oxyde nitrique et derives de polysaccharides |
US8241619B2 (en) * | 2006-05-15 | 2012-08-14 | Medtronic Vascular, Inc. | Hindered amine nitric oxide donating polymers for coating medical devices |
US7811600B2 (en) * | 2007-03-08 | 2010-10-12 | Medtronic Vascular, Inc. | Nitric oxide donating medical devices and methods of making same |
US8273828B2 (en) | 2007-07-24 | 2012-09-25 | Medtronic Vascular, Inc. | Methods for introducing reactive secondary amines pendant to polymers backbones that are useful for diazeniumdiolation |
US8852732B2 (en) * | 2008-01-08 | 2014-10-07 | Johns Manville | Fiber-reinforced composite articles made from fibers having coupling-initiator compounds and methods of making the articles |
US20090232863A1 (en) * | 2008-03-17 | 2009-09-17 | Medtronic Vascular, Inc. | Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers |
US20090232868A1 (en) * | 2008-03-17 | 2009-09-17 | Medtronic Vascular, Inc. | Nitric Oxide Releasing Polymer Composition |
US8158187B2 (en) * | 2008-12-19 | 2012-04-17 | Medtronic Vascular, Inc. | Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices |
US8709465B2 (en) * | 2009-04-13 | 2014-04-29 | Medtronic Vascular, Inc. | Diazeniumdiolated phosphorylcholine polymers for nitric oxide release |
US20110301299A1 (en) | 2010-06-08 | 2011-12-08 | Medtronic Vascular, Inc. | Medical Devices and Polymers Therefor Having PTFE Surfaces Modified With Nitric Oxide-Releasing Polymers |
US9216178B2 (en) | 2011-11-02 | 2015-12-22 | Biomarin Pharmaceutical Inc. | Dry blend formulation of tetrahydrobiopterin |
CN109837594A (zh) * | 2017-11-27 | 2019-06-04 | 上海欧易生物医学科技有限公司 | 一种提高表达文库阳性率的建库方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4652639A (en) * | 1982-05-06 | 1987-03-24 | Amgen | Manufacture and expression of structural genes |
US4882282A (en) * | 1985-08-16 | 1989-11-21 | Immunex Corporation | DNA sequences encoding bovine interleukin-2 |
US5017691A (en) * | 1986-07-03 | 1991-05-21 | Schering Corporation | Mammalian interleukin-4 |
US5239060A (en) * | 1986-07-25 | 1993-08-24 | The Children's Medical Center Corporation | Muscular dystrophy protein, dystrophin |
US5223425A (en) * | 1987-04-02 | 1993-06-29 | The Beth Israel Hospital Association | DNA encoding human adipsin with complement D activity |
US5171674A (en) * | 1988-07-13 | 1992-12-15 | Brigham And Women's Hospital | Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response |
US5216131A (en) * | 1989-02-23 | 1993-06-01 | Genentech, Inc. | Lymphocyte homing receptors |
DE4012928C2 (de) * | 1990-04-24 | 1997-01-09 | Roland Man Druckmasch | Bogentransporttrommel für Schrägregisterkorrektur |
GB2250993B (en) * | 1990-11-21 | 1995-02-15 | Inst Nat Sante Rech Med | Stromelysin-3 and its application in the diagnosis and treatment of malignant breast cancer |
US5268465A (en) * | 1991-01-18 | 1993-12-07 | The Johns Hopkins University | Purification and molecular cloning of nitric oxide synthase |
US5278299A (en) * | 1991-03-18 | 1994-01-11 | Scripps Clinic And Research Foundation | Method and composition for synthesizing sialylated glycosyl compounds |
US5268295A (en) * | 1991-05-31 | 1993-12-07 | W. Alton Jones Cell Science Center, Inc. | Mammalian adipocyte protein p154, nucleic acids coding therefor and uses thereof |
US5132407A (en) * | 1991-09-26 | 1992-07-21 | Cornell Research Foundation, Inc. | Purified inducible nitric oxide synthase flavoprotein |
JPH08503852A (ja) * | 1992-11-25 | 1996-04-30 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブハイヤー エデュケーション | ヒト誘導性一酸化窒素シンターゼのcDNAクローンおよびその作製方法 |
-
1993
- 1993-11-23 JP JP6513344A patent/JPH08503852A/ja active Pending
- 1993-11-23 EP EP94901676A patent/EP0670902A1/fr not_active Withdrawn
- 1993-11-23 WO PCT/US1993/011401 patent/WO1994012645A2/fr not_active Application Discontinuation
- 1993-11-23 CA CA002150125A patent/CA2150125A1/fr not_active Abandoned
-
1994
- 1994-09-28 US US08/314,917 patent/US5468630A/en not_active Expired - Lifetime
-
1995
- 1995-06-05 US US08/465,522 patent/US5882908A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5468630A (en) | 1995-11-21 |
JPH08503852A (ja) | 1996-04-30 |
US5882908A (en) | 1999-03-16 |
WO1994012645A2 (fr) | 1994-06-09 |
EP0670902A1 (fr) | 1995-09-13 |
WO1994012645A3 (fr) | 1994-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5468630A (en) | cDNA clone for human inducible nitric oxide synthase and process for preparing same | |
Prochownik et al. | Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation | |
AU716623B2 (en) | Inducible nitric oxide synthase gene for treatment of disease | |
Matsuda et al. | Molecular cloning of hyoscyamine 6 beta-hydroxylase, a 2-oxoglutarate-dependent dioxygenase, from cultured roots of Hyoscyamus niger | |
Kaghad et al. | Genomic cloning of human thioredoxin-encoding gene: mapping of the transcription start point and analysis of the promoter | |
Lewis et al. | Regulated expression of the tyrosine hydroxylase gene by epidermal growth factor | |
WO1997035989A2 (fr) | Phosphodiesterase de nucleotides cycliques | |
Budillon et al. | Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RII beta regulatory subunit to lose its ability to revert transformed fibroblasts. | |
Choi et al. | The mouse RACK1 gene is regulated by nuclear factor-κB and contributes to cell survival | |
US5932477A (en) | Polynucleotides encoding human brain phosphodiesterase | |
Morris et al. | Saturation mutagenesis at dihydrofolate reductase codons 22 and 31 A variety of amino acid substitutions conferring methotrexate resistance | |
Witter et al. | Cloning, sequencing and functional studies of the gene encoding human GTP cyclohydrolase I | |
Sloane et al. | Cloning and functional expression of the cDNA encoding rat lanosterol 14-α demethylase | |
US6440714B2 (en) | Tyr393 and Tyr398 mutants of monoamine oxidase B | |
WO1993005061A1 (fr) | Clonage et caracterisation d'une adenylyle cyclase cardiaque | |
Jean et al. | Rat liver cytochrome P450 2B3: structure of the CYP2B3 gene and immunological identification of a constitutive P450 2B3-like protein in rat liver | |
Hussain et al. | Construction of a dominant selectable marker using a novel dihydrofolate reductase | |
Huang et al. | Identification of biologically active mutants by combinatorial cassette mutagenesis: exclusion of wild-type codon from degenerate codons | |
Ziegler et al. | Interferon-γ and kit ligand are primary regulators of GTP cyclohydrolase activity: mechanisms and implications | |
EP0658204A1 (fr) | ADN CODANT LA 2$g(a) KINASE DU FACTEUR D'INITIATION EUCARYOTIQUE A REGULATION HEMIQUE | |
US6790646B2 (en) | Mutants of monoamine oxidase B | |
Johnston et al. | N‐terminal amino acid sequence analysis of dihydrofolate reductase from methotrexate‐resistant mosquito cells | |
Yang et al. | The sequence of mouse dihydropteridine reductase cDNA, and comparison with human and rat sequences | |
EP0935661A1 (fr) | Enzyme recombinee kynurenine-3-hydroxylase et son procede de preparation | |
Wilson et al. | A nodulin cDNA with homology to protochlorophyllide reductase. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |